BIOLASE, INC. — Operating Income by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3a4758eb-402c-40d2-9a6d-d624539e0014/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-17.9M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-034812 |
| FY 2022 | $-25.3M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-010364 |
| FY 2021 | $-16.4M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-004115 |
| FY 2020 | $-18.5M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-017121 |
| FY 2019 | $-15.6M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-013794 |
| FY 2018 | $-20.9M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-006918 |
| FY 2017 | $-18.0M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-005648 |
| FY 2016 | $-15.0M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-003972 |
| FY 2015 | $-19.9M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-014571 |
| FY 2014 | $-17.9M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-001392 |
| FY 2013 | $-11.0M | 2013-01-01 – 2013-12-31 | evidence 0001564590-14-000856 |
| FY 2012 | $-2.5M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-110112 |
| FY 2011 | $-4.0M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-112386 |
| FY 2010 | $-11.5M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-112386 |
| FY 2009 | $-3.0M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-112386 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).